1 WO SC 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA 8 9 Frank Jarvis Atwood, No. CV 20-00623-PHX-JAT (JZB) 10 Plaintiff, 11 v. ORDER 12 Panaan Days, et al., 13 Defendants.
14 15 I. Procedural Background 16 Plaintiff Frank Jarvis Atwood, who is confined in the Arizona State Prison 17 Complex-Eyman, filed a pro se civil rights Complaint pursuant to 42 U.S.C. § 1983, a 18 motion for injunctive relief (Doc. 3) with supporting brief (Doc. 4), and paid the filing and 19 administrative fees (Doc. 9). In an April 29, 2020 Order, the Court ordered Defendants 20 Days, Arnold, and Shinn to answer the Complaint and ordered Days and Shinn to respond 21 to the motion (Doc. 10). 22 On July 10, 2020, Defendants Arnold, Days, and Shinn filed their Answer to the 23 Complaint (Doc. 20). On July 21, 2020, Plaintiff filed “Plaintiff’s Notice of Filing an 24 Amended Complaint (as Matter of Course) and Motion to Supplement the Complaint” 25 (Doc. 22) and lodged a proposed First Amended Complaint (Doc. 23). In a September 9, 26 2020 Order (Doc. 37), the Court ordered Plaintiff’s First Amended Complaint filed and 27 ordered Defendants Centurion, Olmstead, Lopez, Days, Arnold, Shinn, and Scott to answer 28 Counts I and IV of the First Amended Complaint (Doc. 37). Plaintiff then filed a second 1 motion for injunctive relief (Doc. 45) concerning the discontinuation of tramadol to treat 2 Plaintiff’s pain and the Court ordered Defendants Centurion and Olmstead to respond to 3 that motion (Docs. 47, 56). Meanwhile, Magistrate Judge Boyle granted Plaintiff’s motion 4 to file a Supplemental Complaint as to Count I (Docs. 51, 52), and this Court ordered 5 Centurion and Olmstead to respond to the Supplemental Complaint (Doc. 56). In the same 6 Order, the Court denied the balance of Plaintiff’s first motion for injunctive relief. 7 On October 2, 2020, Defendants Centurion and Olmstead filed waivers of service, 8 (Docs. 47, 48.) They were subsequently ordered to file an answer to the Supplemental 9 Complaint and to respond to Plaintiff’s second motion for injunctive relief (Docs. 60, 66). 10 Defendants Centurion and Olmstead have filed a response to the second motion for 11 injunctive relief (Doc. 81) and Plaintiff has filed a reply (Doc. 82). Plaintiff has also filed 12 two requests for judicial notice (Docs. 77, 80). 13 On October 28, 2020, Plaintiff filed a third motion for injunctive relief concerning 14 the suspension of in-person religious visitation (Doc. 59). The Court ordered Defendants 15 Shinn and Scott to respond to that motion (Doc. 60). On November 12, 2020, Defendants 16 filed their opposition to the motion (Doc. 64). On November 20, 2020, Plaintiff filed his 17 reply (Doc. 65). 18 II. Standard for Injunctive Relief 19 A plaintiff seeking a preliminary injunction must show that (1) he is likely to 20 succeed on the merits, (2) he is likely to suffer irreparable harm without an injunction, (3) 21 the balance of equities tips in his favor, and (4) an injunction is in the public interest.1 22 Winter v. Natural Resources Defense Council, Inc., 555 U.S. 7, 20 (2008). Where a movant 23
24 1 “But if a plaintiff can only show that there are ‘serious questions going to the merits’—a lesser showing than likelihood of success on the merits—then a preliminary 25 injunction may still issue if the ‘balance of hardships tips sharply in the plaintiff’s favor,’ and the other two Winter factors are satisfied.” Shell Offshore, Inc. v. Greenpeace, Inc., 26 709 F.3d 1281, 1291 (9th Cir. 2013) (quoting Alliance for the Wild Rockies v. Cottrell, 632 F.3d 1127, 1135 (9th Cir. 2011)). Under the serious question variant of the Winter test, 27 “[t]he elements . . . must be balanced, so that a stronger showing of one element may offset a weaker showing of another.” Lopez, 680 F.3d at 1072. Regardless of which standard 28 applies, the movant “has the burden of proof on each element of the test.” See Envtl. Council of Sacramento v. Slater, 184 F. Supp. 2d 1016, 1027 (E.D. Cal. 2000). 1 seeks a mandatory injunction, rather than a prohibitory injunction, injunctive relief is 2 “subject to a higher standard” and is “permissible when ‘extreme or very serious damage 3 will result’ that is not ‘capable of compensation in damages,’ and the merits of the case are 4 not ‘doubtful.’” Hernandez v. Sessions, 872 F.3d 976, 999 (9th Cir. 2017) (quoting Marlyn 5 Nutraceuticals, Inc. v. Mucos Pharma GmbH & Co., 571 F.3d 873, 879 (9th Cir. 2009)). 6 “A mandatory injunction orders a responsible party to take action,” while “a prohibitory 7 injunction prohibits a party from taking action and preserves the status quo pending a 8 determination of the action on the merits.” Marlyn Nutraceuticals, 571 F.3d at 879 9 (internal quotation marks omitted). “The ‘status quo’ refers to the legally relevant 10 relationship between the parties before the controversy arose.” Arizona Dream Act 11 Coalition v. Brewer, 757 F.3d 1053, 1060-61 (9th Cir. 2014). 12 IV. Plaintiff’s Second Motion for Injunctive Relief 13 In his second motion and brief, Plaintiff seeks injunctive relief based upon 14 allegations contained in his Supplemental Complaint (Doc. 52). In the Supplemental 15 Complaint, Plaintiff alleges the following: 16 As of September 2020, Plaintiff had been prescribed tramadol, and ibuprofen, for 17 his severe spinal pain for years.2 Since February 2020, Olmstead had prescribed 50 mg of 18 tramadol in the morning and afternoon and 100 mg at night.3 19 On September 16, 2020, Plaintiff submitted an HNR to Olmstead requesting a 20 renewal of his Tramadol prescription. The evening of September 17, a night nurse told 21 Plaintiff that Olmstead had discontinued the 100 mg dose of Tramadol at night. Plaintiff 22 gave the night nurse an HNR asking Olmstead to renew the 100 mg dose or temporarily 23 provide him codeine. Also, on September 17, Plaintiff submitted an emergency grievance 24 for ibuprofen and tramadol, or codeine, for pain and inflammation. 25
26 2 Various other medications had been prescribed to Plaintiff to alleviate his severe pain but were discontinued as ineffective or causing adverse side-effects. (Docs. 63 at 28; 27 63-1 at 8, 9, 10; 82-1 at 8.) 28 3 Prior to February 2020, Olmstead or other medical providers had prescribed Plaintiff 50mg of Tramadol three times a day. 1 On September 18, 2020, Plaintiff lodged another HNR with Olmstead reporting 2 severe pain and that he was sleeping less than two hours at night without the 100 mg dose 3 of tramadol. Plaintiff also submitted an Informal Resolution regarding Olmstead’s 4 stoppage of the 100 mg dose of tramadol. Because the night dose of tramadol was 5 discontinued, Plaintiff went 19 hours, from 3:00 p.m. to 10 a.m., without receiving 6 tramadol, which resulted in worsening pain, and an inability to sleep. 7 On September 19, Plaintiff submitted another HNR to Olmstead saying that he was 8 only able to sleep an hour and a half due to severe pain. He also reported falling when 9 transferring from his bed to his wheelchair. Olmstead told “Nursing” to respond “no 10 tramadol until Plaintiff’s appointment with Olmstead.” 11 On September 20, an unidentified person told Plaintiff that Olmstead had 12 discontinued tramadol for him entirely. Plaintiff submitted an emergency grievance. He 13 also submitted another HNR reporting severe back, neck, and shoulder pain. At that 14 juncture, Plaintiff had received no tramadol for 22 hours, had fallen a second time, and was 15 suffering from withdrawal symptoms, including flushes, chills, cramps, nausea, and 16 restless legs. At 12:30 p.m. that day, Plaintiff went to the health unit where a nurse told 17 him that she had made Olmstead aware of his multiple HNRs. Olmstead “persisted” in “no 18 Tramadol or alternative, at least until a 9/23 visit[.]” (Doc. 52 ¶ 37.) The week of 19 September 21, 2020, Olmstead reordered ibuprofen for Plaintiff. (Doc. 52 ¶ 38.) 20 On September 23, 2020, Plaintiff saw Olmstead, who told him that because tramadol 21 was addictive, she would no longer prescribe it to him or do anything for his withdrawal 22 symptoms and was “unconcerned” about his falls. (Doc. 52 ¶ 38.) Plaintiff claims that 23 Olmstead stopped or failed to provide him medically necessary medication for his pain and 24 inflammation. He further claims that Olmstead stopped tramadol without weaning him 25 from it first, despite knowing about withdrawal problems. Plaintiff alleges that it was only 26 shortly after this Court’s September 9, 2020 Order that Olmstead reduced and then 27 eliminated the tramadol. He claims that she delayed prescribing ibuprofen for his severe 28 pain. 1 A. Relief Requested 2 Plaintiff seeks an order requiring that he be provided tramadol three times a day, 3 with 50 mg doses in the morning and afternoon and a night dose of 100 mg. (Doc. 45). 4 Plaintiff alleges that immediately after the Court ordered the First Amended Complaint 5 served on Olmstead, Olmstead reduced by half the amount of tramadol Plaintiff had been 6 receiving since February 2020. Olmstead later stopped Plaintiff’s tramadol altogether. 7 Plaintiff asserts that she did so as retaliation for his lawsuit against her4 and alleges that 8 discontinuation of tramadol for his severe pain amounted to deliberate indifference to his 9 serious medical needs. 10 B. Defendants’ Response 11 In their response to Plaintiff’s motion, Defendants Olmstead and Centurion point 12 out that neither was served in this case until September 28, 2020,5 after Plaintiff’s tramadol 13 doses had been reduced and then stopped, thus refuting Plaintiff’s assertion of retaliatory 14 conduct. (Doc. 81.) Defendants also argue that, at most, Plaintiff’s claim represents a 15 disagreement with the diagnosis and recommendations of his providers.6 Defendants 16 submit evidence reflecting the following: 17 On September 19, 2020, Plaintiff’s tramadol prescription expired. (Doc. 81-1 at 3.) 18 At Plaintiff’s September 23, 2020 provider visit, Olmstead declined to renew a prescription 19 for tramadol in light of Plaintiff’s age (64), comorbidities,7 and risk factors associated with 20 Plaintiff’s previous medication usage. (Id. at 5-13.) Instead, Olmstead prescribed
21 4 Plaintiff included a retaliation claim in the Supplemental Complaint, which was 22 dismissed. As discussed below, Plaintiff fails to provide evidence to support that Olmstead knew that he had named her as a Defendant in this case when she reduced and then stopped 23 prescribing him tramadol. 24 5 Waivers of service of summons were filed on October 2, 2020. (Docs. 48, 49.) On October 13, 2020, Plaintiff’s Supplemental Complaint was lodged and was not filed 25 until October 13, 2020 (Doc. 52). 26 6 “A difference of opinion does not amount to deliberate indifference to [a plaintiff’s] serious medical needs.” Sanchez v. Vild, 891 F.2d 240, 242 (9th Cir. 1989). 27 7 Including hypertension, spinal stenosis, disc degeneration, cervical spondylosis, 28 hyperlipidemia, anemia, and coronary artery disease. (See Doc. 81-1 at 26.) In her Affidavit, Olmstead also notes that Plaintiff was a fall risk. (Id. at 43 ¶ 5.) 1 duloxetine (Cymbalta), an alternative non-narcotic medication for Plaintiff’s pain. (Id. at 2 12.) During the visit, Plaintiff told Olmstead that he would raise the interruption of 3 tramadol in court. (Id.) 4 On October 27, 2020, Plaintiff had a telemedicine chronic care appointment with a 5 provider concerning his anemia.8 (Id. at 15-29.) During the visit, Plaintiff discussed his 6 chronic pain and desire to be prescribed tramadol for it. (Id.) Plaintiff reported that 7 duloxetine and Tylenol were not relieving his pain. (Id.) The provider noted that Plaintiff’s 8 situation required an evaluation by an onsite provider and a discussion with Dr. Stewart 9 regarding other pain management options. (Id.) The provider prescribed the use of Tylenol 10 for pain rather than NSAIDS, because of Plaintiff’s history of duodenal ulcer, liver damage, 11 and anemia; noted that an onsite provider needed to evaluate his pain; discontinued 12 duloxetine because of its side effects and failure to alleviate his pain; prescribed the use of 13 topical aspercream lidocaine patches for pain; and ordered laboratory testing concerning 14 his anemia.9 (Id. at 23, 26, 27.) The provider indicated that she would attempt to have 15 Plaintiff seen in pain management and would discuss other management options with Dr. 16 Stewart. (Id. at 23.) 17 On November 17, 2020, Olmstead saw Plaintiff to discuss pain management and 18 Plaintiff requested an MRI to assess spinal deterioration. (Id. at 31-41.) Plaintiff also 19 requested more effective pain medication. (Id. at 31-32.) In addition, Plaintiff reported 20 difficulty with the application of the pain patches on his back, although he was able to 21 apply them during the appointment. (Id.) Olmstead conferred with Assistant Director of 22 Nursing Wischuesen about how to assist Plaintiff in applying the patches properly. (Id.) 23 They agreed to open the packaging for the patches and to cut them in half so that Plaintiff 24 could more easily apply the patches on his back. They also offered to place Plaintiff on 25 the nursing line each day so that nursing staff could apply the patch, but Plaintiff refused
26 8 Physician’s Assistant Bellene Racowsky. (Doc. 81-1 at 15.) 27 9 The provider also ordered monitoring of his blood pressure and follow-up in six 28 months and submitted a request for a CT/MRI of a lesion on Plaintiff’s liver. (Doc. 81-1 at 26.) 1 because he did not want to report every day to medical. (Id.) In her notes, Olmstead stated 2 that an MRI was reasonable under the circumstances and would be necessary for 3 consideration of epidural steroid injections for pain. (Id. at 39.) Olmstead indicated that 4 she began the process to obtain an MRI that day. (Id.) Olmstead noted that she had made 5 clear to Plaintiff that an MRI would be sought in connection with a decision about epidural 6 pain injections and not as a basis to prescribe oral narcotics. (Id.) Olmstead also noted 7 that Plaintiff had been receiving tramadol for years but that it had been discontinued in 8 light of Plaintiff’s age and medical history and the absence of clinical findings to support 9 the use of opioids. (Id. at 31 and at 43 § 6.) She noted that it was “reasonable to consider” 10 a lumbar spine MRI and a repeat cervical spine MRI to assess whether Plaintiff had 11 suffered further degeneration, and that MRIs would also be necessary to consider whether 12 an epidural steroid injection would be appropriate. (Id. at 39.) Olmstead stated that she 13 would submit an MRI request to “Rubicon MD E-Consult”10 to ensure proper imaging plan 14 “before submitting for consult in “EMR.” (Id.) She noted that she told Plaintiff that the 15 MRI would be for purposes of a pain consultation concerning steroid injections and not as 16 a basis for prescribing oral narcotics, which are managed by the “yard provider.” (Id.) 17 On November 27, 2020, Olmstead noted that “per Rubicon MD E-Consult 18 neuros[ur]g11 agrees MRI would be next appropriate diagnostic” and was compatible with 19 Plaintiff having a cervical titanium plate. (Id. at 46.) She noted that she had “submitted” 20 for MRIs of Plaintiff’s cervical and lumbar spine per “Rubicon MD E-Consult Recs.” (Id. 21 at 53.) The record does not reflect whether Centurion has authorized the MRIs or whether 22 the MRIs have been performed. 23 In her Affidavit, Olmstead avers that she has been Plaintiff’s provider since 24 December 2019. (Doc. 81-1 at 43 § 3.) She further stated: 25
26 10 According to its website, RubiconMD eConsults “enable[s] primary care clinicians to easily and quickly discuss their patient cases with top specialists, so they can 27 provide better care[.]” See https://www.rubiconmd.com/ (last accessed December 30, 2020). 28 11 Apparently referring to neurosurgeon. I can avow that the medical decision has been made, after full review 1 of his medical chart, repeat examinations and other testing, that his condition 2 does not require the use of opioid medications, including Tramadol. Tramadol has been at times, a part of his prescription medication regimen, 3 however there is no medical indication to continue this medication at this 4 time. Narcotics are very powerful medications that should only be used in the appropriate case and for the shortest duration needed, which is how they 5 were used. 6 (Id. § 4.)12 7 C. Plaintiff’s Reply 8 In his Reply, Plaintiff notes his longstanding use of tramadol for severe pain. He 9 provides copies of records reflecting that numerous alternatives have been tried and 10 rejected because they did not alleviate his pain or had adverse side-effects. He contends 11 that he is entitled to injunctive relief to require the resumption of tramadol for his severe 12 pain. 13 Documents attached to his Reply, including portions of his medical records dating 14 back to 1990, reflect his longstanding spinal issues.13 The attachments to the Reply reflect 15 the following: 16 On December 11, 2018, neurosurgeon Feiz-Erfan noted that if Plaintiff’s neck pain 17 failed to significantly improve following surgery on cervical vertebrae -4-5, surgery on 18 cervical vertebrae 2-3 might be warranted. (Docs. 82 at 24; 84 at 33.) On February 4, 19 2020, Defendant Olmstead prescribed tramadol three times daily for 90 days.14 (Doc. 82- 20 1 at 8.) Olmstead noted that various other alternatives had been tried but found ineffective 21 or not tolerated. (Id.) On June 1, 2020, Olmstead renewed tramadol for Plaintiff for 90 22
23 12 The Court notes that Olmstead’s averments that Plaintiff was prescribed tramadol 24 “at time” is contradicted by the submitted records reflecting that he had been receiving tramadol for years. 25 13 It is undisputed that Plaintiff suffers from several spinal conditions that cause 26 significant pain, result in falls, and limit his activities. However, it appears that Plaintiff also suffered falls while he was taking tramadol, and it is not apparent that discontinuation 27 of tramadol has increased the risk of falls. 28 14 As described above, two 50 mg doses in the morning and afternoon and 100 mg dose at night. 1 days, with an expiration date of September 7, 2020. (Id. at 9, 10.) Presumably in 2 conjunction with Plaintiff’s September 23, 2020 appointment, Olmstead ordered lumbar 3 spinal x-rays. (Id. at 22.) Olmstead received the results on September 30, 2020, in which 4 Dr. Morrison stated: 5 The bones demonstrate diffuse demineralization. No lytic or blastic lesions are present. There is mild endplate compression. Decrease disc space and 6 marginal osteophyte formation is present throughout. There is scoliosis. 7 CONCLUSION: Scoliosis, degenerative disc disease, and spondylosis. 8 (Id. at 22.) 9 On November 23, 2020, Plaintiff fell, hit his nose on his bed railing, and “awoke” 10 on his cell floor; as he tried to get back on his bed, he fell again, injuring his elbow. (Doc. 11 82 at 2.) 12 D. Discussion 13 As an initial matter, contrary to Plaintiff’s assertion, he seeks mandatory injunctive 14 relief rather than prohibitory injunctive relief because when he filed his motion, he was no 15 longer receiving tramadol, and in his motion, he seeks resumption of his prior pain 16 treatment, i.e., use of tramadol. Thus, the nature of the relief sought is mandatory, not 17 prohibitory. 18 Secondarily, there is no evidence to support that Olmstead reduced and then 19 discontinued tramadol in retaliation for Plaintiff’s lawsuit against her. Treatment with 20 tramadol was discontinued before either Olmstead or Centurion were served and Plaintiff 21 has not submitted evidence to support that either knew they were named prior to service. 22 As to the merits, there is no meaningful dispute that Plaintiff suffers from severe 23 spinal pain, a serious medical condition. There is also no dispute that Plaintiff has tried 24 various other medications to alleviate his pain, all of which were discontinued as 25 ineffective or causing adverse side-effects. Defendants do not dispute that tramadol 26 alleviates the severity of Plaintiff’s pain, and the records before the Court reflect that he 27 was prescribed tramadol for nearly ten years by multiple medical providers including, most 28 recently, Defendant Olmstead. 1 However, the evidence before the Court supports that Olmstead declined to continue 2 to prescribe tramadol to Plaintiff due to its addictive properties and as contraindicated by 3 Plaintiff’s advancing age and other medical conditions and medications, i.e., for medical 4 reasons. Plaintiff does not dispute that tramadol is addictive or that continued use is 5 contraindicated by his age and other conditions and medications. And as discussed above, 6 Plaintiff fails to demonstrate that Olmstead discontinued tramadol for non-medical reasons. 7 Moreover, while Olmstead declined to continue prescribing Plaintiff tramadol, she 8 has taken steps to address Plaintiff’s pain by other means. The evidence before the Court 9 reflects that Olmstead has sought authorization for MRIs of Plaintiff’s lumbar and cervical 10 spine to assess whether there has been further deterioration, which could support surgery 11 or the epidural spinal injections to alleviate his pain without the risks posed by continuing 12 to take tramadol long-term. In addition, Olmstead has facilitated the provision of lidocaine 13 pain patches, which Plaintiff concedes give him some relief. In short, while Olmstead 14 discontinued prescribing Plaintiff tramadol, she is seeking alternative means to treat his 15 pain, such as epidural injections, referral to pain management, and, possibly, additional 16 surgery. That is sufficient to refute an allegation that Olmstead acted with deliberate 17 indifference to Plaintiff’s serious medical needs. Plaintiff therefore fails to establish a 18 likelihood of success on the merits of his medical claim concerning discontinuation of 19 tramadol. 20 To the extent that Plaintiff is suffering increased pain and disability, those are 21 symptoms of his underlying medical conditions. They are not alone sufficient to establish 22 irreparable injury—at least at this juncture—where Defendants are evaluating the use of 23 methods other than oral narcotics to address his severe pain. Inasmuch as Plaintiff has not 24 demonstrated a likelihood of success on the merits or irreparable harm, the Court finds that 25 the balance of the equities and the public interest do not weigh in favor of granting 26 Plaintiff’s second motion for injunctive relief. 27 The Court’s conclusion that Plaintiff is not entitled to injunctive relief on this record 28 does not minimize the severe pain and discomfort that he clearly experiences daily. For 1 that reason, the Court strongly encourages Defendants to expedite consideration of ways 2 to better manage Plaintiff’s pain, whether via epidural injections or other means. A 3 prolonged failure to address Plaintiff’s severe pain through other means may well warrant 4 consideration of a new motion for injunctive relief. 5 V. Plaintiff’s Third Motion for Injunctive Relief 6 In his third motion and Count IV of the First Amended Complaint, Plaintiff asserts 7 a claim for violation of his religious exercise rights. Plaintiff alleges the following: 8 On August 13, 2014, Plaintiff settled Atwood v. Linderman, CV 13-00174, an action 9 concerning his religious exercise rights.15 Under the settlement agreement in that case, 10 former director Ryan and former Pastoral Activities Administrator Linderman agreed that 11 Plaintiff could receive a religious visit every two weeks, during which he could participate 12 in the sacraments with a Greek Orthodox priest. (Doc. 23 at 17 ¶ 2.) 13 Until March 11, 2020, Plaintiff received a two-hour religious visit every other week, 14 but those visits stopped after visitation was suspended by the Arizona Department of 15 Corrections (ADC) due to the COVID-19 pandemic. (Id. ¶ 3.) Both legal and non-legal 16 visitation have been suspended since that time because of the ongoing pandemic. (See 17 Doc. 65 at 21.) On May 10, 2020, video visitation was implemented to facilitate prisoner 18 visitation for one 15-minute video visit per week to allow as many prisoners as possible to 19 participate. (Id.) 20 From March to May 2020, Plaintiff approached his counselor, a Corrections Officer 21 III, seeking religious visitation. (Doc. 23 ¶ 4.) On May 3, 2020, Plaintiff submitted a 22 grievance regarding the denial of religious visitation.16 (Id. ¶ 5.) On June 9, 2020, 23 Defendant Scott denied the grievance. (Id. ¶ 6.) Defendant Shinn failed to respond to 24 Plaintiff’s grievance appeal. (Id.) 25
26 15 The Settlement Agreement did not provide that the Court would retain jurisdiction to enforce it. Atwood, CV 13-00174, Doc. 55-1. 27 16 Plaintiff states that “reference was made” to the relative safety of “confronting a 28 dozen or so officers and nurses face-to-face daily,” in contrast to non-contact religious services every other week with a masked priest and socially distanced staff. (Id.) 1 At some point, Plaintiff sought video visitation with a priest, which was also denied. 2 Plaintiff appealed that denial. Plaintiff does not identify the persons involved or allege 3 when these events occurred. 4 As his injury, Plaintiff alleges that he is being denied the ability to exercise his 5 religious rights through in-person religious visitation. Plaintiff claims that Defendants 6 Scott and Shinn were personally informed of Plaintiff’s attempt to exercise his religious 7 rights but intentionally denied him that ability by refusing to except him from in-person 8 visitation restrictions and affording longer video visitation for religious visitation. (Id. at 9 17.) 10 A. Requested Relief 11 In his October 28, 2020 motion, Plaintiff seeks an injunction requiring prison 12 officials to grant him in-person religious visitation. In an October 28 Order, the Court 13 ordered Defendants Shinn and Scott to respond to Plaintiff’s motion. The Court also 14 ordered the parties to address in their response and reply (1) whether and how Plaintiff’s 15 religious exercise rights can be accommodated in light of the COVID-19 pandemic and (2) 16 the availability and potential frequency and duration of in-person or video visitation. On 17 November 12, 2020, Defendants Days and Shinn filed their opposition (Doc. 64) to 18 Plaintiff’s motion. On November 18, 2020, Plaintiff filed his reply to their response (Doc. 19 65). 20 B. Defendants’ Response 21 In their response, Defendants Shinn and Deputy Warden Days argue Plaintiff’s 22 motion should be denied because he fails to state a claim for relief based upon the denial 23 of religious visitation,17 his claim is moot, and he does not meet the standard for injunctive 24 relief. (Doc. 64.) 25 Defendants state that they complied with the terms of the settlement in Plaintiff’s 26 previous case until the advent of the COVID-19 pandemic. On March 13, 2020, ADC 27 17 In screening the First Amended Complaint, the Court found that Plaintiff had 28 stated a claim in Count IV against Defendants Shinn and Scott for violation of Plaintiff’s religious exercise rights. Therefore, the Court does not further consider this contention. 1 suspended visitation, both legal and non-legal, reevaluating the decision every 30 days in 2 light of the ongoing pandemic. Defendants represent that all visitation is canceled, 3 including legal, Child Protective Services, Consulate, Probation Officers, volunteer 4 program staff, prisoner educators, and in-service training. They represent that prisoners 5 attend court via videoconferencing, rather than in person.18 Defendants cite the 6 implementation of video visitation for prisoners, initially for 15-minutes per week, and 7 then to 30-minutes per week, to accommodate visitation for as many prisoners as possible 8 during the pandemic. 9 Defendants argue that Plaintiff has not shown that he will suffer irreparable injury 10 under the circumstances. They note that COVID-19 has the potential to kill those who 11 contract it and argue that the suspension of in-person visitation to prevent the spread of a 12 potentially deadly virus is not an unreasonable impingement on Plaintiff’s religious 13 exercise. They further argue that Plaintiff may practice his religion individually or through 14 other means (presumably through reading, writing, meditation, etc.). Defendants dispute 15 Plaintiff’s claims that “hundreds” or “dozens” of workers enter his unit daily,19 16 representing that only persons necessary to provide food and medical care are admitted to 17 the unit.20 Defendants argue that the pandemic is a temporary emergency that is beyond 18 the control of the ADC. They represent that video visitation resources are finite, 19 particularly where video conferencing is necessary for court appearances as well as 20 visitation generally. They argue that Plaintiff’s unit has approximately 800 prisoners and 21 that it would be unfair to allow Plaintiff video visitation with his priest in addition to 22 general video visitation and that allowing him two-hour visitation every other week with 23 his priest “could mean” other prisoners would not be able to participate in visitation.
24 18 As alluded to by Defendants, both state and federal courts in Arizona, as 25 elsewhere, have resorted to video-conferencing for court proceedings and suspended jury trials due to COVID-19. 26 19 Defendants also note that Plaintiff makes no attempt to reconcile the discrepancy 27 in these estimates. 28 20 Defendants also presumably intended to include security staff are admitted to the unit to maintain the safety of prisoners and staff. 1 Finally, Defendants argue that even if Plaintiff received two-hour visitation every other 2 week, he still would be unable to receive the sacraments, which can only be provided in 3 person. 4 C. Plaintiff’s Reply 5 In his reply, Plaintiff argues that Defendants have violated the terms of the 6 settlement in his previous case. Plaintiff claims Defendants are disingenuous in citing the 7 pandemic as the reason for suspending visitation where more than 100 people enter the unit 8 daily. Plaintiff also indicates that a chaplain suggested that he could use his weekly 15- 9 minute video visitation for religious visitation but argues that 15 minutes is not even 10 minimally sufficient and argues that he should not be required to use his general visitation 11 time for religious visitation. He claims, for the first time, that video visits are recorded and 12 are not confidential, which breaks the confessional seal. Further, he agrees that video 13 visitation cannot accommodate the reception of Holy Communion, which Plaintiff 14 describes as the centerpiece of his religious practice. Plaintiff argues that Defendants have 15 failed to show that the suspension of all in-person visitation is the least restrictive means 16 to protect prisoners and staff from contracting COVID-19. 17 D. Discussion 18 To the extent that Plaintiff argues that Defendants’ suspension of religious visitation 19 violates the terms of the settlement in his previous case, Plaintiff cannot seek relief in this 20 case on that basis. Standing alone, a settlement agreement cannot serve as a substantive 21 basis for a § 1983 claim for relief because it does not create “rights, privileges, or 22 immunities secured by the Constitution and [federal] laws.” Green v. McKaskle, 788 F.2d 23 1116, 1123-24 (5th Cir. 1986). Further, failure to comply with the terms of a private 24 settlement agreement, absent more, is not enforceable in federal court. 18 U.S.C. 25 § 3626(c); see O’Connor v. Colvin, 70 F.3d 530, 532 (9th Cir. 1995); cf. Rushdan v. 26 Perbula, No. 07-15244, 2008 WL 4430669, at *2 (9th Cir. Sept. 8, 2008). Further, section 27 3626(a) of title 18 imposes limits on prospective relief in any civil action with respect to 28 prison conditions. Parties may enter a “private settlement” that does not comply with the 1 limitations on prospective relief stated in § 3626(a) only so long as the terms of such 2 agreement are not subject to court enforcement, other than reinstatement of the civil 3 proceeding.21 A “private settlement agreement” is defined as “an agreement entered into 4 among the parties that is not subject to judicial enforcement other than the reinstatement of 5 the civil proceeding that the agreement settled.” 18 U.S.C. § 3626(g)(6). 6 This Court did not retain jurisdiction to enforce the terms of the settlement in 7 Plaintiff’s previous case. Accordingly, Plaintiff cannot seek to enforce that settlement in 8 this case. 9 To the extent Plaintiff is asserting a claim under RLUIPA, that Act provides that the 10 government may not substantially burden an incarcerated person’s religious exercise. If a 11 prisoner establishes that his religious exercise has been substantially burdened, the burden 12 shifts to the defendant to show that the challenged policy furthers a compelling 13 governmental interest and that the policy was the least restrictive means of furthering that 14 compelling governmental interest. See Uhuru v. Bonnifield, No. 2:19cv10449, 2020 WL 15 6534087, at 12 (C.D. Cal. Oct. 27, 2020). Assuming, without deciding, that Plaintiff’s 16 religious exercise has been substantially burdened by the suspension of in-person 17 visitation, Plaintiff has not demonstrated that the government lacked a compelling 18 governmental in suspending such visitation to reduce the spread of COVID-19, which can 19 debilitate and kill those who contract it, within ADC facilities. See Uhuru, 2020 WL 20 6534087, at 10 (noting the compelling governmental interest in protecting prisoners from 21 contracting COVID-19). Prisons and jails around State and the country have suspended 22 in-person programs because of the pandemic. See e.g., Wilson v. Conn. Dep’t of Corr., 23 No. 3:20cv1567, 2020 WL 7388979, at *2 (D. Conn. Dec. 16, 2020); Uhuru, 2020 WL 24 6534087, at *10 (there is a compelling governmental interest in protecting prisoners and 25 staff from contracting a potentially fatal or debilitating virus); Payne v. Sutterfield, No. 26 2:17cv211, 2020 WL 5237747, at *6 (N.D. Tex. Sept. 2, 2020); Ousman D. v. Decker, No.
27 21 18 U.S.C. § 3626(c)(2)(A). A party claiming a breach of a private settlement 28 agreement is not precluded from seeking any remedy available under state law in state court. 18 U.S.C. § 3626(c)(2)(B). 1 20cv2292, 2020 WL 1847704, at *2 (D. N.J. Apr. 13, 2020). See also Spell v. Edwards, 2 962 F.3d 175, 181-82 (Ho, J., concurring) (“Officials may take appropriate emergency 3 public health measures to combat a pandemic,” including assembly rights, even though 4 nothing “supports the view that an emergency displaces normal constitutional standards.”); 5 In re Abbott, 954 F.3d 772, 784-85 (5th Cir. 2020) (Duncan, J.) (citing cases supporting 6 principle that public health crises may temporarily permit extraordinary government 7 intrusion on constitutional liberties to combat contagion ). 8 Thus, Plaintiff essentially contends that suspension of in-person visitation is not the 9 least restrictive means of furthering a compelling governmental interest. He points to the 10 dozens of workers who enter his unit daily, but he does not dispute that those workers 11 perform essential functions, such as providing food and medical services to prisoners or 12 ensuring the safety of both prisoners and staff. (Doc. 65 at 7 ¶ 5.) Plaintiff has made no 13 showing that in-person visitation, legal or non-legal, is currently being allowed. Plaintiff 14 also does not dispute that approximately 800 prisoners are confined in his unit or that 15 Defendants have implemented procedures to allow all prisoners at least some video 16 visitation, while in-person visitation is suspended.22 Further, Plaintiff does not dispute that 17 he has other means to practice his religion, individually through reading, writing, or 18 meditation, or via video visitation or phone calls, during the suspension of in-person 19 visitation. 20 The Court concludes that given the pandemic and, in particular, the rate of COVID- 21 19 infection throughout Arizona,23 suspension of visitation is the least restrictive means of 22 furthering the compelling governmental interest in preventing the spread of COVID-19 to 23 prison staff and prisoners. The Court notes that vaccines have been developed and are in 24 the process of being administered as supplies become available. The most recent ADC 25 COVID-19 Management Strategy reflects that prison medical staff have completed the 26
27 22 Defendants indicate that video visitation has been increased to 30 minutes a week. 28 23 See https://azdhs.gov/preparedness/epidemiology-disease-control/infectious- disease-epidemiology/covid-19/dashboards/index.php (last accessed Jan. 8, 2021). 1 | process to be certified to administer the vaccine as supplies become available.” 2 Given the exigencies of the current pandemic, resulting in the temporary suspension of in-person visitation, and Plaintiffs ability to practice his faith via other means until the 4| pandemic subsides,” the Court finds Plaintiff has not established a likelihood of success 5 | on the merits or the risk of irreparable harm. Nor does the Court find that the balance of 6| the equities or the public interest tip in Plaintiff's favor. Plaintiff's third motion for 7 | injunctive relief will therefore be denied. 8| ITIS ORDERED: 9 (1) The reference to Magistrate Judge Boyle is withdrawn as to Docs. 45 and 10) 59. 11 (2) Plaintiff’s second motion for injunctive relief (Doc. 45) and third motion for 12 | injunctive relief (Doc. 59) are denied. 13 Dated this 12th day of January, 2021. 14 15 16 1 James A. Teilborg 7 Senior United States District Judge 18 19 20 21 22 23 24 25 4 See https://corrections.az.gov/covid-19-management-updates, December 28, 26 | 2020 (last accessed Jan. 6, 2021) (describing ongoing testing in the prison system and noting that prison medical staff have completed the process to become certified COVID- 19 vaccines during the appropriate phases for administration of the vaccines). 28 °5 Although Plaintiff argues that in-person visitation is necessary for him to receive the sacraments, which he considers the centerpiece of his religious faith, he has not identified when these rites must be administered or how frequently.